Cov yam ntxwv ntawm GHRP-2
GHRP {{0}} yog ib qho hluavtaws hexapeptide nrog cov tshuaj npe D-alanyl-3-(2-naphthyl)-D-alanyl-L-alanyl-L-tryptophan-D-phenylalanyl -L-Lysinamide hydrochloride, dihydrochloride. Qhov no yog luv peptide saw, kuj ruaj khov. Ib nrab-lub neej ntawm GHRP-2 hauv cov ntshav yog kwv yees li 30 feeb. Qhov ncauj bioavailability theem tsis zoo (0.3-1 feem pua ); qhov ntswg bioavailability yog siab ntawm kwv yees li 53 feem pua; kev txhaj tshuaj yog li ntawd txoj kev nyiam ntawm kev tswj hwm.
Kev txiav txim siab rau GHRP-2
GHRP-2 yuav tsum tau siv nrog ceev faj rau cov neeg mob qaug dab peg. Kev rog rog, hypothyroidism, hyperglycemia, lossis nce ntshav plasma fatty acids tuaj yeem cuam tshuam cov txiaj ntsig ntawm GHRP-2. Tsis txhob siv cov tshuaj no thaum cev xeeb tub, mob qog noj ntshav, keeb kwm ntawm mob qog noj ntshav, ntshav qab zib retinopathy, daim siab cirrhotic lossis kab mob ntsws, intracranial siab, lossis ntshav qab zib tsis tswj tau.
GHRP-2 Cov Kev Phem Phem (General)
Cov kev mob tshwm sim feem ntau ntawm GHRP-2 kev kho mob suav nrog dej ntws, tawm hws, lethargy, glycemic Performance index
Nce thiab nce qab los noj mov, dej tuav, mob pob qij txha, carpal tunnel syndrome, thiab loog los yog tingling nyob rau hauv cov extremities. Nco ntsoov tias GHRP-2 muaj qhov tshwm sim qis dua ntawm cov kev mob tshwm sim piv rau cov tshuaj hormones exogenous loj hlob. Qhov no yog vim qhov tso tawm ntawm GH / IGF-1 cuam tshuam los ntawm endogenous synthesis.
GHRP-2 Sab Nraud (Qhov Chaw Txhaj Tshuaj)
Kev txhaj tshuaj no subcutaneously tuaj yeem ua rau liab, khaus, mob, lossis pob ntawm qhov chaw txhaj tshuaj. Kev txhaj tshuaj intramuscular kuj qee zaum cuam tshuam nrog liab thiab tsis xis nyob ntawm qhov chaw txhaj tshuaj.
Dosage ntawm GHRP-2
GHRP-2 tuaj yeem muab tau los ntawm kev tswj hwm intranasal, txhaj tshuaj subcutaneous (SC) lossis intramuscular (IM) txhaj. Txawm li cas los xij, vim tias nws cov nqi thiab bioavailability tsawg los ntawm lwm txoj kev, nws yog siv yuav luag tsuas yog txhaj tshuaj.
Thaum siv los txhim kho lub cev qoj ib ce lossis kev ua kis las, GHRP {{0}} yog siv ntawm koob tshuaj 0.1 txog 0.3 mg (100-300 mcg) rau ib qho kev txhaj tshuaj. Tswj 1-3 zaug hauv ib hnub. Yog tias koj xaiv ib koob tshuaj, nws yuav tsum tau siv ua ntej mus pw, thiab nws raug nquahu kom siv nws ntawm lub plab khoob. Qhov no yog los xyuas kom meej qhov kev tso tawm GH ua tau zoo tshaj plaws, vim tias cov ntshav plasma fatty acids thiab / lossis cov piam thaj tuaj yeem cuam tshuam GH-txo cov teebmeem ntawm GHRP-2. Tag nrho cov koob tshuaj txhua hnub feem ntau tsis tshaj 900mcg.
Cov koob tshuaj feem ntau yog maj mam nce los ntawm 100mcg rau ib qho kev txhaj tshuaj. Cov koob tshuaj tuaj yeem nce ntxiv hauv 50mcg increments txhua 3-7 hnub kom txog rau thaum cov koob tshuaj ruaj khov tiav.
GHRP-2 cycles feem ntau kav ntev 3-4 lub hlis, txawm hais tias lub voj voog ntawm 6 lub hlis lossis ntev dua kuj muaj ntau. Desensitization rau GHRP tuaj yeem tshwm sim nyob rau lub sijhawm, tab sis cov tshuaj kuj tseem tuaj yeem tswj tau qhov kev siv tau zoo hauv lub voj voog ntev dua.
Txhua yam kev xav tau, thov hu rau kuv
Email: amyraws195@gmail.com
Whatsapp: ntxiv rau 86-17507125642
Telegram: ntxiv rau 86-17507125642
Cim npe nrov: 10mg/vial ghrp-2 cas 158861-67-7 nrog tus nqi zoo, Tuam Tshoj 10mg/vial ghrp-2 cas 158861-67-7 nrog tus nqi zoo manufacturers, lwm tus neeg, Hoobkas
